The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells. - Russo D; Spina A; Portella L; Bello AM; Galdiero F; Trotta AM; Ieranò C; Rea G; Cecere SC; Coppola E; Di Maro S; Pignata S; et al. (PloS one, 2024)